Diphenylcyclopropenone

DRUG2 trials

Sponsors

Rockefeller University, Innovaderm Research Inc.

Conditions

Healthy VolunteersHypersensitivity, DelayedImmune Tolerance/Drug EffectsImmunosuppressionUltraviolet Rays

Phase 1

Effect of RANKL Inhibition on UV-induced Immunosuppression

CompletedNCT01978483

Innovaderm Research Inc.Hypersensitivity, Delayed, Immune Tolerance/Drug Effects, Immunosuppression +1

Start: 2013-11-30End: 2014-06-30Updated: 2014-07-24

Unknown Phase

Analysis of Diphenylcyclopropenone (DPCP) in Normals

CompletedNCT01452594

Rockefeller UniversityHealthy Volunteers

Start: 2011-10-31End: 2013-09-30Target: 30Updated: 2013-09-05